$57.92
2.59%
Nasdaq, Sep 23, 04:01 pm EDT. Closed.
ISIN
CA10919W4056
Symbol
DRUG

Bright Minds Biosciences Inc Stock price

$57.92
-19.11 24.80% 1M
-14.55 20.08% 6M
-20.12 25.78% YTD
+7.82 15.61% 1Y
+56.17 3,207.07% 3Y
+50.91 726.25% 5Y
+52.57 982.62% 10Y
+52.57 982.62% 20Y
Nasdaq, Closing price Wed, Sep 23 2026
-2.75 4.53%
ISIN
CA10919W4056
Symbol
DRUG
Industry

Is Bright Minds Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$596.9m
Enterprise Value
$377.4m
Net debt
positive
Cash
$219.6m
Shares outstanding
9.8m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
2.7
Financial Health
Equity Ratio
97.2%
Return on Equity
-14.9%
ROCE
-10.1%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | -
EBITDA
$-22.0m
EBIT
$-22.1m
Net Income
$-19.4m
Free Cash Flow
$-14.1m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-472.5%
EBIT
-465.5%
Net Income
-694.7%
Free Cash Flow
-378.2%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$-2.0
FCF per Share
$-1.4
Short interest
11.8%
Employees
-
Rev per Employee
-

Bright Minds Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Bright Minds Biosciences Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Bright Minds Biosciences Inc forecast:

Buy
86%
Hold
14%

Financial data from Bright Minds Biosciences Inc

Mar '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 3.47 3.47
148% 148%
-
- Research and Development Expense 19 19
495% 495%
-
-22 -22
472% 472%
-
- Depreciation and Amortization 0.05 0.05
17% 17%
-
EBIT (Operating Income) EBIT -22 -22
466% 466%
-
Net Profit -19 -19
695% 695%
-

In millions USD.

Don't miss a Thing! We will send you all news about Bright Minds Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bright Minds Biosciences Inc Stock News

Neutral
GlobeNewsWire
about 2 months ago
SOUTH SAN FRANCISCO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced the appointment of Douglas J.

Company Profile

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company is headquartered in New York City, New York. The company went IPO on 2021-02-08. The firm is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The firm has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.

Head office Canada
CEO Mr. Mcdonald
Website brightmindsbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today